# Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

> **NCT04220398** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 475 (estimated)

## Conditions studied

- Prostate Cancer
- Chemotherapy Effect
- Hormone Sensitive Prostate Cancer
- Locally Advanced Prostate Carcinoma

## Interventions

- **DRUG:** Neoadjuvant chemotherapy combined with hormone therapy
- **DRUG:** Neoadjuvant hormone therapy
- **PROCEDURE:** Radical Prostatectomy (RP)+ extended lymph node dissection

## Key facts

- **NCT ID:** NCT04220398
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-10
- **Primary completion:** 2022-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 475 (ESTIMATED)
- **Last updated:** 2020-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04220398

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04220398, "Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04220398. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*